BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2447679)

  • 41. Cross-reactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27+ patients with ankylosing spondylitis.
    Husby G; Tsuchiya N; Schwimmbeck PL; Keat A; Pahle JA; Oldstone MB; Williams RC
    Arthritis Rheum; 1989 Apr; 32(4):437-45. PubMed ID: 2468338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of HLA-B27 antigen with monoclonal antibodies.
    Engleman EG; Calin A; Grumet FC
    J Rheumatol Suppl; 1983 Nov; 10():59-61. PubMed ID: 6420568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Status of an unpaired thiol group on the HLA-B27 epitope.
    McLean L; Perrett D; Winrow VR; Archer JR
    Clin Exp Immunol; 1989 Sep; 77(3):417-21. PubMed ID: 2478324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.
    Taurog JD; el-Zaatari FA
    J Clin Invest; 1988 Sep; 82(3):987-92. PubMed ID: 2458390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies.
    Parham P; Antonelli P; Herzenberg LA; Kipps TJ; Fuller A; Ward FE
    Hum Immunol; 1986 Jan; 15(1):44-67. PubMed ID: 2419285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA-B27 antigenicity: antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1 display alloantigenic specificity and discriminate among HLA-B27 subtypes.
    Rojo S; López de Castro JA; Aparicio P; Van Seventer G; Bragado R
    J Immunol; 1986 Aug; 137(3):904-10. PubMed ID: 2424988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations.
    Weiss EH; Kuon W; Dörner C; Lang M; Riethmüller G
    Immunobiology; 1985 Dec; 170(5):367-80. PubMed ID: 3912316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.
    Toubert A; Raffoux C; Boretto J; Sire J; Sodoyer R; Thurau SR; Amor B; Colombani J; Lemonnier FA; Jordan BR
    J Immunol; 1988 Oct; 141(7):2503-9. PubMed ID: 2459214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retro-inverso peptide analogues of Trypanosoma cruzi B13 protein epitopes fail to be recognized by human sera and peripheral blood mononuclear cells.
    Iwai LK; Duranti MA; Abel LC; Juliano MA; Kalil J; Juliano L; Cunha-Neto E
    Peptides; 2001 Jun; 22(6):853-60. PubMed ID: 11390013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allo-antibodies to an antigenic determinant shared by HLA-A2 and B17.
    Claas F; Castelli-Visser R; Schreuder I; van Rood J
    Tissue Antigens; 1982 May; 19(5):388-91. PubMed ID: 6180520
    [No Abstract]   [Full Text] [Related]  

  • 51. HLA-B40, B18, B27, and B37 allele discrimination using group-specific amplification and SSCP method.
    Bannai M; Tokunaga K; Lin L; Ogawa A; Fujisawa K; Juji T
    Hum Immunol; 1996 Apr; 46(2):107-13. PubMed ID: 8727209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A cytotoxic human hybridoma monoclonal antibody (TrJ5) specific for HLA-B38(16) and -B39(16).
    Ge J; Hannestad K
    Hum Immunol; 1993 Mar; 36(3):168-71. PubMed ID: 7686545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein.
    Toubert A; Hamachi M; Raffoux C; Park MS; Yu DT
    Clin Exp Immunol; 1990 Oct; 82(1):16-20. PubMed ID: 1698580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12.
    Schäfer K; Albert ED; Rodt H; Thierfelder S
    Immunogenetics; 1980; 10(6):595-602. PubMed ID: 22457938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. Evidence for molecular mimicry in the spondyloarthropathies.
    Raybourne RB; Bunning VK; Williams KM
    J Immunol; 1988 May; 140(10):3489-95. PubMed ID: 3283236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cross-reacting HLA-B alleles as genetic markers of HLA-B27 negative ankylosing spondylitis].
    Haberhauer G; Bröll H
    Z Rheumatol; 1986; 45(5):260-2. PubMed ID: 3492838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurement of HLA class I expression in ankylosing spondylitis.
    Creamer P; Edmonds J; Sullivan J; Matthews S
    Ann Rheum Dis; 1992 Oct; 51(10):1138-42. PubMed ID: 1444627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria.
    Kono DH; Ogasawara M; Effros RB; Park MS; Waldord RL; Yu DT
    Clin Exp Immunol; 1985 Sep; 61(3):503-8. PubMed ID: 3878239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mimicry between human leukocyte antigen B27 and Klebsiella. Consequences for spondyloarthropathies.
    Schwimmbeck PL; Oldstone MB
    Am J Med; 1988 Dec; 85(6A):51-3. PubMed ID: 2462350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoimmune pathogenesis for ankylosing spondylitis (AS) and Reiter's syndrome (RS): autoantibodies against an epitope shared by HLA B27 and Klebsiella pneumoniae nitrogenase in sera of HLA B27 patients with AS and RS.
    Schwimmbeck PL; Oldstone MB
    Trans Assoc Am Physicians; 1987; 100():28-39. PubMed ID: 2457977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.